Annexon, Inc.
Anti-complement factor C1q Fab fragments and uses thereof
Last updated:
Abstract:
The present disclosure relates generally to anti-C1q antibody Fab fragments and methods of using the same.
Status:
Grant
Type:
Utility
Filling date:
23 Nov 2016
Issue date:
28 Jul 2020